NEW DELHI (Reuters) – The Serum Institute of India has sought regulatory approval to make Russia’s Sputnik V COVID-19 vaccine, local media reported on Thursday, on top of the AstraZeneca PLC and Novavax Inc shots it is already producing.
(Reporting by Krishna N. Das; Editing by Christopher Cushing)
